JP2022500034A5 - - Google Patents

Info

Publication number
JP2022500034A5
JP2022500034A5 JP2021513327A JP2021513327A JP2022500034A5 JP 2022500034 A5 JP2022500034 A5 JP 2022500034A5 JP 2021513327 A JP2021513327 A JP 2021513327A JP 2021513327 A JP2021513327 A JP 2021513327A JP 2022500034 A5 JP2022500034 A5 JP 2022500034A5
Authority
JP
Japan
Prior art keywords
peptides
cells
antigen
library
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021513327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500034A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050492 external-priority patent/WO2020055931A1/en
Publication of JP2022500034A publication Critical patent/JP2022500034A/ja
Publication of JP2022500034A5 publication Critical patent/JP2022500034A5/ja
Withdrawn legal-status Critical Current

Links

JP2021513327A 2018-09-10 2019-09-10 抗原特異的tリンパ球ならびに抗原特異的tリンパ球を作製および使用する方法 Withdrawn JP2022500034A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862729220P 2018-09-10 2018-09-10
US62/729,220 2018-09-10
US201962884527P 2019-08-08 2019-08-08
US62/884,527 2019-08-08
PCT/US2019/050492 WO2020055931A1 (en) 2018-09-10 2019-09-10 Antigen-specific t lymphocytes and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2022500034A JP2022500034A (ja) 2022-01-04
JP2022500034A5 true JP2022500034A5 (cg-RX-API-DMAC7.html) 2022-09-21

Family

ID=69778456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513327A Withdrawn JP2022500034A (ja) 2018-09-10 2019-09-10 抗原特異的tリンパ球ならびに抗原特異的tリンパ球を作製および使用する方法

Country Status (7)

Country Link
US (1) US20220033766A1 (cg-RX-API-DMAC7.html)
EP (1) EP3849569A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022500034A (cg-RX-API-DMAC7.html)
AU (1) AU2019339332A1 (cg-RX-API-DMAC7.html)
CA (1) CA3112471A1 (cg-RX-API-DMAC7.html)
IL (1) IL281339A (cg-RX-API-DMAC7.html)
WO (1) WO2020055931A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190902A1 (en) * 2020-05-29 2023-06-22 Children's National Medical Center Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame
WO2024026452A1 (en) 2022-07-29 2024-02-01 Repertoire Immune Medicines, Inc. T cell epitopes associated with type 1 diabetes
US20260234258A1 (en) 2022-10-20 2026-08-13 Repertoire Immune Medicines, Inc. Cd8 t cell targeted il2
WO2025072849A1 (en) 2023-09-29 2025-04-03 Repertoire Immune Medicines, Inc. Mhc-presentable peptides associated with type 1 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE038833T2 (hu) * 2005-08-05 2018-11-28 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Antigénspecifikus T-sejtek létrehozása
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
US20140081012A1 (en) 2011-02-15 2014-03-20 The University Of North Carolina At Chapel Hill Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
CA3191031A1 (en) 2013-09-27 2015-04-02 Massachusetts Institute Of Technology Carrier-free biologically-active protein nanostructures
MX2017000630A (es) * 2014-07-15 2017-04-27 Immune Design Corp Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral.
AU2016305087B2 (en) 2015-08-12 2022-01-20 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles

Similar Documents

Publication Publication Date Title
Den Haan et al. CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo
Silk et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
Ahlers et al. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection
JP5127224B2 (ja) 予防又は治療目的のためのmhcクラスi拘束性エピトープに対する免疫応答を誘発し、増強し、維持する方法
Galea-Lauri et al. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination
CN100337686C (zh) 从前体产生加载有抗原的树突细胞疫苗的快速一步法
Okada et al. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens
NL2009102C2 (en) Method for dc-loading.
JP2002504322A (ja) 樹状細胞に対するアポトーシス細胞介在抗原提示
US20020155108A1 (en) Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
AU2008303453B2 (en) An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
CA2348956A1 (en) Immunotherapeutic methods using epitopes of wt-1 and gata-1
JP5016489B2 (ja) 抗原提示ヒトγδT細胞の調製及び免疫療法における使用
EP3424522A1 (en) System and method of preparing and storing activated mature dendritic cells
US20140141046A1 (en) Method and composition for producing a cellular allogeneic vaccine
JP2011504101A5 (cg-RX-API-DMAC7.html)
Dhodapkar et al. Active immunization of humans with dendritic cells
CN101031641A (zh) 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途
US20230357718A1 (en) Methods and materials for expanding antigen-specific t cells in culture
JP2023539056A (ja) T細胞を製造する組成物および方法
CN1353575A (zh) 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t-销细胞
Reichardt et al. Dendritic cells in vaccination therapies of human malignant disease
Tirapu et al. Cytokine gene transfer into dendritic cells for cancer treatment
Fields et al. Comparative analysis of murine dendritic cells derived from spleen and bone marrow
JP2023513605A5 (cg-RX-API-DMAC7.html)